Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Human umbilical cord mesenchymal stem cell gel for refractory wounds
ChiCTR2400086845Phase 2Not yet recruiting
- Sponsor
- First Medical Center of Chinese PLA General Hospital
- Start
- Jul 2024
- Countries
- 1
01
Overview
Phase 2, open-label trial of human umbilical cord mesenchymal stem cell in Chronic wound (4 arms), sponsored by First Medical Center of Chinese PLA General Hospital. Primary endpoints: Wound healing rate, Wound healing time and 1 more. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
human umbilical cord mesenchymal stem cell
03
Conditions
Chronic wound
Beyond the preview
Go deeper on ChiCTR2400086845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400086845.